Clinical Trials on Ocular Abnormalities in United States

Total 14176 results

University of Colorado, Denver
Merck Sharp & Dohme LLC

Completed

RESEARCH PROTOCOL: Glaucoma Treatment Adherence and Persistence

Primary Open Angle Glaucoma

United States
Alcon Research

Not yet recruiting

A Double-Masked Comparison of FID 123320 Ophthalmic Solution to Vehicle for the Reduction of Ocular Redness

Ocular Redness

United States
New Jersey Institute of Technology
National Eye Institute (NEI)

Completed

Neural Mechanism of Vision Therapy for Patients With Convergence Insufficiency

Convergence Insufficiency

United States
University of Arkansas

Withdrawn

Effect of Meibomian Gland Probing on Ocular Surface in Ocular Rosacea

Meibomian Gland Dysfunction

United States
Allergan

Completed

Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma

Ocular Hypertension | Glaucoma, Open-Angle

United States
Nidek Co. LTD.

Completed

OCT Agreement and Crossed Precision Study

Glaucoma | Retinal Disease | Corneal Disease

United States
Alcon Research

Completed

A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)

Ocular Hypertension | Glaucoma, Open-Angle

United States
Heidelberg Engineering GmbH

Terminated

Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-1)

Glaucoma

United States
Wills Eye

Recruiting

Caffeine Consumption in Glaucoma Patients and Healthy Subjects

Glaucoma, Primary Open Angle

United States
Alcon Research

Completed

24 Hour IOP Lowering Efficacy of AL-3789

Open-angle Glaucoma

United States
University of the Incarnate Word
Guardion Health Sciences, Inc.

Withdrawn

Augmented Macular Pigment-containing Nutraceutical and Central Visual Function

Glaucoma | Glaucoma, Open-Angle | Glaucoma Eye

United States
Allergan

Completed

Study Comparing Quantitative Assessments in Open-angle Glaucoma (OAG) and/or Ocular Hypertension (OHT)

Ocular Hypertension | Glaucoma, Open-Angle

United States
Wills Eye

Completed

Dose, Effects and Characteristics of Pilocarpine

Open-angle Glaucoma

United States
Mid-Atlantic Glaucoma Experts

Completed

Ability of Patients With Low Vision to Properly Instill Eye Drops

Glaucoma | Retinal Pathology

United States
Allergan

Completed

Safety and Effects of Brimonidine Intravitreal Implant in Patients With Glaucomatous Optic Neuropathy

Glaucoma, Open-Angle

Israel, United States
Barnes Retina Institute
Genentech, Inc.

Unknown

Ranibizumab Versus PDT for Presumed Ocular Histoplasmosis

Presumed Ocular Histoplasmosis (POHS)

United States
Icahn School of Medicine at Mount Sinai
University of California, Los Angeles; National Eye Institute (NEI)

Recruiting

Snapshot Camera for AMD

Age Related Macular Degeneration

United States
National Eye Institute (NEI)

Recruiting

Dark Adaptation in Participants With Age-Related Macular Degeneration

Age-Related Macular Degeneration

United States
National Eye Institute (NEI)

Recruiting

Study of Dark Adaptation in Age-Related Macular Degeneration

Age-Related Macular Degeneration

United States
Ophthotech Corporation

Completed

ARC1905 (ANTI-C5 APTAMER) Given Either In Combination Therapy With Lucentis® 0.5 mg/Eye In Subjects With Neovascular Age-Related Macular Degeneration

Age-Related Macular Degeneration

United States
Ophthotech Corporation

Completed

A Study of ARC1905 (Anti-C5 Aptamer) in Subjects With Dry Age-related Macular Degeneration

Age-Related Macular Degeneration

United States
National Eye Institute (NEI)

Completed

Palomid 529 in Patients With Neovascular Age-Related Macular Degeneration

Age-Related Macular Degeneration

United States
Maturi, Raj K., M.D., P.C.

Completed

Sirolimus Versus Anti-Vascular Endothelial Growth Factor (antiVEGF) for Wet AMD

Age-Related Macular Degeneration

United States
David M. Brown, M.D.
Regeneron Pharmaceuticals

Completed

Study for Recalcitrant Age Related Macular Degeneration (TURF)

Age Related Macular Degeneration

United States
Retina Center, Minnesota
Genentech, Inc.

Completed

ERG/EOG Study in AMD Patients Treated With Ranibizumab (FVF4154s)

Age-Related Macular Degeneration

United States
Sequenom, Inc.
Center for Eye Research and Education

Completed

Evaluation of the Association Between Genetic Load and Response to Anti-VEGF Therapy in AMD Patients (EVERGREEN)

Age Related Macular Degeneration

United States
Weill Medical College of Cornell University

Completed

High-Resolution Ultrasound Imaging of the Retina and Choroid for Detection on Age Related Macular Degeneration

Age Related Macular Degeneration

United States
National Eye Institute (NEI)

Completed

Visual Function and Ocular Pigmentation in Albinism

Albinism | Albinism, Oculocutaneous | Albinism, Ocular

United States
Glia, LLC

Active, not recruiting

Safety and Efficacy of Pro-ocular™ 1% in Daily Scleral Lens Wearing Patients With Ocular Graft-versus-Host Disease

Ocular Graft-versus-host Disease

United States
Wills Eye

Completed

Does Adding Bevacizumab Therapy in Glaucoma Surgery Improve the Success of Needle Bleb Revisions? (Avastin)

Glaucoma

United States
Allergan

Completed

Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG)

Ocular Hypertension | Open-Angle Glaucoma

United States
University of Illinois at Chicago
VitreoRetinal Surgery Foundation; Illinois Society for the Prevention of Blindness

Completed

Effect of Oral Curcumin Supplementation in Dry Age-related Macular Degeneration (AMD) Patients

Age Related Macular Degeneration

United States
David M. Brown, M.D.
Novartis Pharmaceuticals

Terminated

Lucentis Utilizing Visudyne (LUV Trial) Combination Therapy in the Treatment of Age-Related Macular Degeneration

Age-Related Macular Degeneration

United States
Thomas Jefferson University
Johns Hopkins University; Dartmouth-Hitchcock Medical Center

Completed

Improving Function in Age-Related Macular Degeneration (IF-AMD)

Age-Related Macular Degeneration

United States
East Florida Eye Institute
Genentech, Inc.

Unknown

Comparison of Pharmacokinetics of and Effect on Systemic VEGF Levels in Age Related Macular Degeneration Patients

Age Related Macular Degeneration

United States
MacuCLEAR, Inc.

Completed

A Pilot Study of the Safety of MC-1101 in Both Normal Volunteers and Patients With Early Dry AMD

Age-Related Macular Degeneration

United States
Eyetech Pharmaceuticals
Pfizer

Terminated

Macugen (Pegaptanib Sodium) Alone, Versus Macugen in Combination With PDT (Photodynamic Therapy) With Visudyne (Verteporfin) in Patients With Age-Related Macular Degeneration (AMD)

Age-Related Macular Degeneration

United States
The New York Eye & Ear Infirmary
iHealthScreen Inc

Recruiting

Telemedicine in Age-Related Macular Degeneration

Age Related Macular Degeneration

United States
ORA, Inc.

Terminated

Visual Function Tests in Age-related Macular Degeneration

Age Related Macular Degeneration

United States
National Eye Institute (NEI)

Completed

AMD Ryan Initiative Study (ARIS)

Age-Related Macular Degeneration

United States
Maturi, Raj K., M.D., P.C.

Completed

RBM-007 in Treatment naïve Exudative Age-related Macular Degeneration (TEMPURA)

Age Related Macular Degeneration

United States
Kubota Vision Inc.

Completed

Study Evaluating Retinal Health Monitoring System Visual Acuity Module.

Age Related Macular Degeneration

United States
Astellas Institute for Regenerative Medicine

Withdrawn

Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMD (PORTRAY)

Age-Related Macular Degeneration

United States
Johns Hopkins University
Alimera Sciences; pSiVida Limited

Completed

The MAP Study: Fluocinolone Acetonide (FA)/Medidur (TM) for Age Related Macular Degeneration (AMD) Pilot (MAP)

Age Related Macular Degeneration

United States
Paloma Pharmaceuticals, Inc.

Completed

Phase I Study of Palomid 529 a Dual TORC1/2 Inhibitor of the PI3K/Akt/mTOR Pathway for Advanced Neovascular Age-Related Macular Degeneration (P52901)

Age-Related Macular Degeneration

United States
Oregon Health and Science University
Genentech, Inc.

Completed

Combination Ranibizumab and Bromfenac for Neovascular Age-related Macular Degeneration

Age-Related Macular Degeneration

United States
Sight Sciences, Inc.

Not yet recruiting

A Clinical Trial Comparing the OMNI Surgical System to Standard Medical Treatment in Pseudophakic Eyes (EVOLVE)

Primary Open Angle Glaucoma

United States
University of California, San Diego
National Eye Institute (NEI)

Recruiting

Diagnostic Innovations in Glaucoma Study (DIGS)

Primary Open Angle Glaucoma | Myopia

United States
Alcon Research

Completed

A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)

Ocular Hypertension | Glaucoma, Open-Angle

United States
Vistakon Pharmaceuticals

Completed

Safety and Efficacy of a Glaucoma Drug Delivery System

Ocular Hypertension | Glaucoma, Open-Angle

United States

Clinical Trials on Ocular Abnormalities in United States

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations